Journal Information
Editorials
Original articles / originales
T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease
Bernardino Alcázar-Navarrete, Jose Manuel Díaz-Lopez, Paula García-Flores, Marina Ortega-Antelo, Ivan Aguilar-Cruz, Oliverio Ruiz-Rodríguez, Pablo Santiago-Diaz, Pedro José Romero Palacios
Arch Bronconeumol. 2022;58:595-600
Full text access

Open Article
Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease: A Stratified, Randomized, Controlled Trial
Kang-Cheng Su, Hsin-Kuo Ko, Yi-Han Hsiao, Kun-Ta Chou, Yen-Wen Chen, Wen-Kuang Yu, Sheng-Wei Pan, Jia-Yih Feng, Diahn-Warng Perng
Arch Bronconeumol. 2022;58:601-10
Open access

Open Article
Clinical images
Scientific letters
Assessment of Quantiferon®-CMV and Immuknow® Assays in CMV-seropositive Lung Transplant Recipients to Stratify Risk of CMV Infection
Víctor Monforte, Helena Sintes, Piedad Ussetti, Raquel Castejón, Virginia Luz Pérez, Rosalía Laporta, Amparo Sole, José Manuel Cifrián, ... Susana Gómez-Ollés
Arch Bronconeumol. 2022;58:614-7
Full text access
Open Article
Predictors of Malignancy in Patients With Haemoptysis
Michele Mondoni, Paolo Carlucci, Giuseppe Cipolla, Nicolò Vanoni, Alessandro Fois, Pietro Pirina, Antonella Arcadu, Stefano Gasparini, ... Giovanni Sotgiu
Arch Bronconeumol. 2022;58:618-20
Full text access
Open Article
Safety and Feasibility of Transbronchial Cryobiopsy in Mechanically Ventilated Patients
Alfons Torrego, Ana M. Muñoz-Fernández, Carmen Mª Lucena, Pedro Castro, Laura López-Vilaró, Joan Ramón Badía, Antoni Betbesé, Josep Ramirez, ... Carles Agustí
Arch Bronconeumol. 2022;58:621-3
Full text access
Open Article
Successful Long-Term Treatment Combining Omalizumab and Anti-IL-5 Biologics in Allergic Bronchopulmonary Aspergillosis
Daniel Laorden, Ester Zamarrón, Javier Domínguez-Ortega, David Romero, Santiago Quirce, Rodolfo Álvarez-Sala
Arch Bronconeumol. 2022;58:624-6
Full text access
Open Article